Hashimoto Etsuko
Department of Internal Medicine and Gastroenterology, Tokyo Women's Medical University.
Nihon Rinsho. 2006 Jun;64(6):1025-32.
Nonalcoholic fatty liver disease (NAFLD) is now emerging as the most common liver disease in Japan. NAFLD is mainly comprised of simple fatty liver that is considered benign, though some patients have nonalcoholic steatohepatitis (NASH), which can progress to cirrhosis and hepatocellular carcinoma. The diagnosis of NASH was based on the following criteria: (1) intake of less than 20 g of ethanol per day, (2) biopsy proven steatohepatitis; steatosis, inflammatory infiltrates, and ballooning degeneration with or without Mallory bodies or pericellular/perivenular fibrosis, (3) appropriate exclusion of other liver diseases. The detection of NASH is usually delayed, since there are no serum surrogate markers for NASH, and a definitive diagnosis requires a liver biopsy.
非酒精性脂肪性肝病(NAFLD)目前正成为日本最常见的肝脏疾病。NAFLD主要由被认为是良性的单纯性脂肪肝组成,不过一些患者患有非酒精性脂肪性肝炎(NASH),这种疾病可能会发展为肝硬化和肝细胞癌。NASH的诊断基于以下标准:(1)每天乙醇摄入量少于20克;(2)活检证实为脂肪性肝炎;存在脂肪变性、炎症浸润以及气球样变性,伴或不伴有马洛里小体或细胞周/血管周纤维化;(3)适当排除其他肝脏疾病。由于没有NASH的血清替代标志物,且明确诊断需要进行肝脏活检,所以NASH的检测通常会延迟。